MEGAN C. TIMMINS
CIK 1733798 · EVP, CLO & Secretary · last filed 2026-07-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$218.4K
Companies
3
Total Filings
19
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RMTI | EVP, CLO & Secretary | 31,240 | $6.99 | $218.4K | $0 | 10 | 2026-07-06 |
| Assertio Holdings, Inc. (ASRT) Delisted | SVP, Gen Csl & Sec | 3,175 | $23.50 | $74.6K | $0 | 1 | 2020-05-22 |
| Zyla Life Sciences (EGLT) Delisted | General Counsel | 206,500 | — | — | $0 | 2 | 2018-06-15 |
Recent Filings · Page 2 of 2
19 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-05-22 | Assertio Holdings, Inc. (ASRT) Delisted | Grant (A) | +190,480 | $0 | EDGAR |
| 2020-05-21 | — | Disp (D) | −107,951 | $0 | |
| 2020-03-26 | — | Mixed | +24,899 | $39.8K | |
| 2020-03-05 | — | Grant (A) | +58,000 | $0 | |
| 2020-03-02 | — | Mixed | +29,290 | $43.9K | |
| 2019-03-28 | — | Grant (A) | +63,000 | $0 | |
| 2019-02-04 | — | Disp (D) | −206,500 | $0 | |
| 2018-06-15 | Zyla Life Sciences (EGLT) Delisted | Grant (A) | +125,000 | $0 | EDGAR |
| 2018-03-08 | Zyla Life Sciences (EGLT) Delisted | Grant (A) | +80,000 | $0 | EDGAR |
Showing 11–19 of 19
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.